Global S&T Development Trend Analysis Platform of Resources and Environment
Lipid-lowering drugs not a risk factor in COVID-19 | |
admin | |
2021-12-03 | |
发布年 | 2021 |
语种 | 英语 |
国家 | 德国 |
领域 | 资源环境 |
正文(英文) | Statins do not increase infectivity or viral replication of SARS-CoV-2. Statins are prescribed to lower cholesterol levels. High blood lipid levels are often associated with diseases of the cardiovascular system. Patients taking these drugs therefore belong to the particularly vulnerable risk group for severe courses of COVID-19 infection. On the one hand, previous studies have shown that there is an association between statin use and lower COVID-19 mortality. ... |
URL | 查看原文 |
来源平台 | Helmholtz Association |
文献类型 | 新闻 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/342887 |
专题 | 资源环境科学 |
推荐引用方式 GB/T 7714 | admin. Lipid-lowering drugs not a risk factor in COVID-19. 2021. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[admin]的文章 |
百度学术 |
百度学术中相似的文章 |
[admin]的文章 |
必应学术 |
必应学术中相似的文章 |
[admin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论